Cargando…

Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients

BACKGROUND: Non-invasive ventilation (NIV) and percutaneous gastrostomy (PEG) are guideline-recommended interventions for symptom management in amyotrophic lateral sclerosis (ALS). Their effect on survival is controversial and the impact on causes of death is unknown. OBJECTIVE: To investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burkhardt, Christian, Neuwirth, Christoph, Sommacal, Andreas, Andersen, Peter M., Weber, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441602/ https://www.ncbi.nlm.nih.gov/pubmed/28542233 http://dx.doi.org/10.1371/journal.pone.0177555

Ejemplares similares

Nine Hole Peg Test and Transcranial Magnetic Stimulation: Useful to Evaluate Dexterity of the Hand and Disease Progression in Amyotrophic Lateral Sclerosis
por: Czell, David, et al.
Publicado: (2019)

Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: López-Gómez, Juan J., et al.
Publicado: (2021)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)
por: Ferrer-Donato, Agueda, et al.
Publicado: (2021)

In-vivo evaluation of neuronal and glial changes in amyotrophic lateral sclerosis with diffusion tensor spectroscopy
por: Reischauer, Carolin, et al.
Publicado: (2018)

Sleep and Survival in Amyotrophic Lateral Sclerosis (ALS): The Parallelism in Motor and Non-Motor Progression
por: Hiew, FL
Publicado: (2023)

Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
por: Mavlyutov, Timur A., et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis (ALS) Awareness Month — May 2013
Publicado: (2013)

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
por: Fournier, Christina N.
Publicado: (2022)

Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
por: Seki, Soju, et al.
Publicado: (2023)

An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis
por: Fathi, Davood, et al.
Publicado: (2019)

ALS2 mutations: Juvenile amyotrophic lateral sclerosis and generalized dystonia
por: Sheerin, Una-Marie, et al.
Publicado: (2014)

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance
por: Wagner, Laurie, et al.
Publicado: (2016)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

MRI Study of Paraspinal Muscles in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: Diamanti, Luca, et al.
Publicado: (2020)

The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
por: Ferrer‐Donato, Agueda, et al.
Publicado: (2021)

Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)
por: Halliday, Vanessa, et al.
Publicado: (2021)

Percutaneous Endoscopic Gastrostomy Placement under NIV in Amyotrophic Lateral Sclerosis with Severe Ventilatory Dysfunction: A Safe and Effective Procedure
por: Gaspar, Rui, et al.
Publicado: (2021)

Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
por: Uenal, Hatice, et al.
Publicado: (2014)

Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan
por: Yu, Yu, et al.
Publicado: (2014)

Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population
por: Korner, Sonja, et al.
Publicado: (2019)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
por: Limpert, Allison S, et al.
Publicado: (2013)

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Yunusova, Yana, et al.
Publicado: (2016)

Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment
por: Schram, Sarah, et al.
Publicado: (2020)

Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
por: Suzuki, Naoki, et al.
Publicado: (2020)

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
por: Boddy, Sarah L., et al.
Publicado: (2021)

Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: García-García, Raquel, et al.
Publicado: (2021)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
por: Maksimovic, Katarina, et al.
Publicado: (2023)

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis
por: Simmatis, Leif, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2021)

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
por: Lingor, Paul, et al.
Publicado: (2019)

Functional and Endoscopic Indicators for Percutaneous Endoscopic Gastrostomy (PEG) in Amyotrophic Lateral Sclerosis Patients
por: Conde, Bebiana, et al.
Publicado: (2018)

The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population
por: Ye, Shan, et al.
Publicado: (2016)

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5s6r5bq2g0d57bsl3jhl16s06a